Washington, D.C., USA- January 13, 2020: FDA Sign at its headquarters in Washington DC. The Food and Drug Administration (FDA or USFDA) is a federal agency of the USA.
Prime Food Processing Recalls Dried Herring Over Botulism Risk From Uneviscerated Fish
BROOKLYN, N.Y. – June 2, 2026 – Prime Food Processing LLC has issued a voluntary recall of 69 cases of “Dried Herring Fish” because the product was not adequately eviscerated, the company announced Tuesday.
The recalled product is packaged in clear, plastic 7 oz. (198 g) bags with blue trim, under Item #AF4110, Lot Code: 26020, with an expiration date of 06.12.28. The product was distributed to Asian grocery stores in Arizona, California, Florida, Hawaii, Illinois, Kansas, Louisiana, Maryland, Missouri, North Carolina, New Hampshire, Nevada, New York, Oklahoma, Pennsylvania, Texas, and Utah.
The sale of uneviscerated fish is prohibited under New York State Agriculture and Markets regulations because Clostridium botulinum spores are more likely to be concentrated in the viscera than in any other portion of the fish. Uneviscerated fish have been linked to outbreaks of botulism poisoning.
Symptoms of botulism include dizziness, blurred or double vision, and trouble with speaking or swallowing. Difficulty in breathing, weakness of other muscles, abdominal distension, and constipation may also be common symptoms. People experiencing these problems should seek immediate medical attention.
The issue was identified during routine testing conducted by the New York Department of Agriculture and Markets. The recall was initiated after the product was selected and sent for regulatory testing. A subsequent investigation determined that the problem originated from an imported product manufactured in Vietnam.
To date, no illnesses or adverse reactions associated with the affected product have been reported.
Consumers who purchased these products should return them to the place of purchase with the uneaten fish and packaging for a full refund. Consumers with questions may contact Prime Food Processing LLC at 718-963-2323, Monday through Friday, 9:00 AM to 5:00 PM EST.
Haleon Recalls Gas-X Extra Strength Softgels Over Coolant Contamination Risk
WARREN, N.J. – June 4, 2026 – Haleon has issued a voluntary nationwide recall of four lots of Gas-X Extra Strength Softgels 125mg due to potential contamination with a diluted propylene glycol-based coolant from a machine leakage during the packaging process, the company announced Thursday.
The recall affects 120-count and 72-count bottles of Gas-X Extra Strength Softgels that were distributed on or about April 13, 2026. The product is indicated to quickly break up gas bubbles in the digestive tract and relieve pressure, bloating, and discomfort. Gas-X Extra Strength Softgels are uniquely identified as a green capsule and found in packaging with a green band.
Ingestion of the Softgels contaminated with the diluted propylene glycol-based coolant may result in adverse events such as nausea, vomiting, abdominal pain, and diarrhea. To date, Haleon has not received any reports of adverse events related to this recall.
| Product | UPC | Lot Number | Expiry Date | Dates of Distribution |
|---|---|---|---|---|
| Gas-X Extra Strength Softgels (120 ct.) | 300674350419 | TL8K YH9X YH9Y | 30 Nov 2028 30 Nov 2028 30 Nov 2028 | 13 Apr 2026 – 05 May 2026 |
| Gas-X Extra Strength Softgels (72 ct.) | 300439005721 | X78N | 30 Nov 2028 | 05 May 2026 – 14 May 2026 |
No other lots of Gas-X Extra Strength, Gas-X Ultra, Gas-X Maximum, or Gas-X Ultimate are impacted by this recall.
Haleon is notifying distributors and customers by letter, email, and phone notification and is arranging for the return of all recalled products. The root cause of the contamination has been identified and repaired, and corrective and preventative actions have been implemented to prevent future recurrence.
Consumers who purchased Gas-X Extra Strength Softgels on or after April 13, 2026, should review the lot number. If the lot number matches those impacted by this recall, they should stop taking the product immediately and contact the Haleon Consumer Relations team at +1-800-245-1040, Monday through Friday from 8:00 AM to 6:00 PM ET, or via email at mystory.us@haleon.com, or through the online contact form to arrange for return of the product and request reimbursement.
Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this product. Adverse reactions or quality problems may also be reported to the FDA’s MedWatch Adverse Event Reporting program online, by regular mail, or by fax.
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
About the Author
